{
  "meta": {
    "title": "Pharmacology_Pre-Test",
    "url": "https://brainandscalpel.vercel.app/pharmacology-pre-test-0823baab.html",
    "scrapedAt": "2025-11-30T08:52:24.029Z"
  },
  "questions": [
    {
      "id": 1,
      "choices": [
        {
          "id": 1,
          "text": "<p><span style=\"font-size:12.0pt;\">Non-competitive antagonist</span></p>"
        },
        {
          "id": 2,
          "text": "<p><span style=\"font-size:12.0pt;\">Competitive antagonist</span></p>"
        },
        {
          "id": 3,
          "text": "<p><span style=\"font-size:12.0pt;\">Inverse agonist</span></p>"
        },
        {
          "id": 4,
          "text": "<p><span style=\"font-size:12.0pt;\">Functional antagonist</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">An investigator is studying the interaction between a new drug B and an existing drug A. The results are recorded and plotted on the graph shown. Which of the following properties of drug B best explain the observed effect on the dose-response curve of drug A?<br><img class=\"w-100\" style=\"height:auto;display:block;vertical-align: middle;border:0; \"src=\"https://d10ehao5y6v0v4.cloudfront.net/V2LBNEETPG/PreTestQuiz/Pharmacology25112024/1Q.jpg\"></span></p>",
      "unique_key": "Q237691",
      "question_audio": null,
      "question_video": null,
      "map_id": 237691,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1000005
      ],
      "solution": "<p>A shift in the 'dose vs. response' graph indicates a change in the efficacy or potency of a drug caused by the presence of another drug.</p><p>Drugs that they antagonize and would cause the original dose-response curve (A, blue line) to shift to the right (A+B, purple line), reflecting a decrease in potency and maintains the same efficacy (i.e., the maximum effect is the same) is called Competitive antagonist.</p><br><img class=\"w-100\" style=\"height:auto;display:block;vertical-align: middle;border:0; \"src=\"https://d10ehao5y6v0v4.cloudfront.net/V2LBNEETPG/PreTestQuiz/Pharmacology25112024/1E.jpg\"><br><img class=\"w-100\" style=\"height:auto;display:block;vertical-align: middle;border:0; \"src=\"https://d10ehao5y6v0v4.cloudfront.net/V2LBNEETPG/PreTestQuiz/Pharmacology25112024/1E1.jpg\"><br><p><strong>Reference:</strong> Basic &amp; Clinical Pharmacology by Bertram G. Katzung Fourteenth Edition Pg no. 22</p>",
      "correct_choice_id": 2,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 2,
      "choices": [
        {
          "id": 11,
          "text": "<p><span style=\"font-size:12.0pt;\">Carbachol</span></p>"
        },
        {
          "id": 12,
          "text": "<p><span style=\"font-size:12.0pt;\">Physostigmine</span></p>"
        },
        {
          "id": 13,
          "text": "<p><span style=\"font-size:12.0pt;\">Benztropine</span></p>"
        },
        {
          "id": 14,
          "text": "<p><span style=\"font-size:12.0pt;\">Pralidoxime</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 76-year-old man with Alzheimer disease is brought with abdominal cramps, diarrhea, diaphoresis, and muscular weakness and spasms in his extremities. He has ingested excessive amount of medications in a suicide attempt. His temperature is 38.4&deg;C (101.1&deg;F), pulse is 51/min, respirations are 12/min and labored, and blood pressure is 88/56 mm Hg. Treatment is initiated. Shortly after, most of his symptoms have resolved, but he continues to have muscular spasms. Administration of which of the following is the most appropriate next step in treatment of this patient?</span></p>",
      "unique_key": "Q237692",
      "question_audio": null,
      "question_video": null,
      "map_id": 237692,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1000005
      ],
      "solution": "<p>This patient presents with symptoms of muscarinic acetylcholine excess (e.g., diarrhea, diaphoresis, bradycardia, bronchospasm, salivation, lacrimation, miosis) and nicotinic acetylcholine excess (e.g.,muscle weakness). Atropine can only reverse the muscarinic effects.</p><p>When taken in excess, medications for Alzheimer disease such as donepezil can result in symptoms similar to that of organophosphate poisoning. In such cases, pralidoxime is given to restore activity of acetylcholinesterase, which then catalyzes the breakdown of excessive acetylcholine to reverse symptoms. Atropine does not act on nicotinic cholinergic receptors and thus cannot treat symptoms of neuromuscular dysfunction, for which pralidoxime is still necessary.</p><p>Pralidoxime has poor blood-brain barrier penetration and can lead to a transient worsening of acetylcholinesterase inhibition following administration, which is why atropine is typically administered first to treat CNS symptoms and prevent further acetylcholinesterase inhibition.</p><p>Management of patient with suspected OP poisoning</p><ul><li>Patient decontamination (e.g., remove clothes, wash skin)</li><li>Secure airways, oxygen therapy, ECG</li><li>Measurement of erythrocyte cholinesterase activity : &darr; acetylcholinesterase activity</li><li>Medication</li><ul><li>Atropine</li><li>Oximes: pralidoxime (2-PAM), obidoxime</li><ul><li>Regenerate acetylcholinesterase by dephosphorylation</li><li>Function peripherally on both muscarinic and nicotinic receptors</li><li>Should only be administered after atropine due to risk of transient worsening of acetylcholinesterase inhibition</li></ul><li>Benzodiazepines (e.g., diazepam): to control organophosphate-induced seizures.</li></ul></ul><p>A &amp; B: They would further exacerbate this patient's symptoms of acetylcholine excess and must be avoided in this patient.</p><p>C: Benztropine is a selective antagonist of muscarinic receptors that particularly decreases cholinergic overactivity in the CNS. It is typically used to treat tremor in Parkinson disease and extrapyramidal symptoms caused by antipsychotics. However, since this patient's muscarinic symptoms have mostly resolved following the administration of atropine, an additional muscarinic inhibitor would not be particularly useful.</p><br><img class=\"w-100\" style=\"height:auto;display:block;vertical-align: middle;border:0; \"src=\"https://d10ehao5y6v0v4.cloudfront.net/V2LBNEETPG/PreTestQuiz/Pharmacology25112024/2E.jpg\"><br><img class=\"w-100\" style=\"height:auto;display:block;vertical-align: middle;border:0; \"src=\"https://d10ehao5y6v0v4.cloudfront.net/V2LBNEETPG/PreTestQuiz/Pharmacology25112024/2E1.jpg\"><p><strong>Reference:</strong> Basic &amp; Clinical Pharmacology, Fourteenth Edition By Bertram G. Katzung Pg no. 114</p>",
      "correct_choice_id": 14,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 3,
      "choices": [
        {
          "id": 21,
          "text": "<p><span style=\"font-size:12.0pt;\">1-c, 2-b, 3-a, 4-d</span></p>"
        },
        {
          "id": 22,
          "text": "<p><span style=\"font-size:12.0pt;\">1-c, 2-a, 3-b, 4-d</span></p>"
        },
        {
          "id": 23,
          "text": "<p><span style=\"font-size:12.0pt;\">1-d, 2-a, 3-b, 4-c</span></p>"
        },
        {
          "id": 24,
          "text": "<p><span style=\"font-size:12.0pt;\">1-c, 2-b, 3-d, 4-a</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Match the following drugs with their indication<br><img class=\"w-100\" style=\"height:auto;display:block;vertical-align: middle;border:0; \"src=\"https://d10ehao5y6v0v4.cloudfront.net/V2LBNEETPG/PreTestQuiz/Pharmacology25112024/3Q.jpg\"></span></p>",
      "unique_key": "Q237693",
      "question_audio": null,
      "question_video": null,
      "map_id": 237693,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1000005
      ],
      "solution": "<img class=\"w-100\" style=\"height:auto;display:block;vertical-align: middle;border:0; \"src=\"https://d10ehao5y6v0v4.cloudfront.net/V2LBNEETPG/PreTestQuiz/Pharmacology25112024/3E.jpg\"><br><p><strong>Reference:</strong> Basic &amp; Clinical Pharmacology, Fourteenth Edition By Bertram G. Katzung Pg no. 118</p>",
      "correct_choice_id": 21,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 4,
      "choices": [
        {
          "id": 31,
          "text": "<p><span style=\"font-size:12.0pt;\"><img class=\"w-100\" style=\"height:auto;display:block;vertical-align: middle;border:0; \"src=\"https://d10ehao5y6v0v4.cloudfront.net/V2LBNEETPG/PreTestQuiz/Pharmacology25112024/4A.jpg\"></span></p>"
        },
        {
          "id": 32,
          "text": "<p><span style=\"font-size:12.0pt;\"><img class=\"w-100\" style=\"height:auto;display:block;vertical-align: middle;border:0; \"src=\"https://d10ehao5y6v0v4.cloudfront.net/V2LBNEETPG/PreTestQuiz/Pharmacology25112024/4B.jpg\"></span></p>"
        },
        {
          "id": 33,
          "text": "<p><span style=\"font-size:12.0pt;\"><img class=\"w-100\" style=\"height:auto;display:block;vertical-align: middle;border:0; \"src=\"https://d10ehao5y6v0v4.cloudfront.net/V2LBNEETPG/PreTestQuiz/Pharmacology25112024/4C.jpg\"></span></p>"
        },
        {
          "id": 34,
          "text": "<p><span style=\"font-size:12.0pt;\"><img class=\"w-100\" style=\"height:auto;display:block;vertical-align: middle;border:0; \"src=\"https://d10ehao5y6v0v4.cloudfront.net/V2LBNEETPG/PreTestQuiz/Pharmacology25112024/4D.jpg\"></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Examiner has asked you to identify the drug in viva-voice: 'When administered by intravenous bolus, the blood pressure increases. When given orally for 1 week, the blood pressure decreases'. What drugs you will pick up from the table ?</span></p>",
      "unique_key": "Q237694",
      "question_audio": null,
      "question_video": null,
      "map_id": 237694,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1000005
      ],
      "solution": "<p>The dual blood pressure effects of the drug suggest that initially it is causing a direct a-agonist vasoconstrictor effect, but when given for a week, it is accumulating in a blood pressure-controlling centre, eg, the CNS, and reducing sympathetic outflow via &alpha;2 effects. Here, out of given drugs, only clonidine acts as &alpha;2 agonist.</p><p>Option A: Prop</p><p>Option D: Prazosin is used in hypertension, acts as &alpha;1 blockers. NOT &alpha;2 agonist.</p><p>Option C: Tamsulosin, selective &alpha;1 blockers, acts on Internal urinary spinchter to contract, is used to reduce urinary hesitancy and prevent urinary retention in men with benign prostatic hyperplasia (BPH).</p><p><strong>Reference:</strong> Basic &amp; Clinical Pharmacology, Fourteenth Edition By Bertram G. Katzung, Pg no. 149.</p>",
      "correct_choice_id": 32,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 5,
      "choices": [
        {
          "id": 41,
          "text": "<p><span style=\"font-size:12.0pt;\">Atenolol</span></p>"
        },
        {
          "id": 42,
          "text": "<p><span style=\"font-size:12.0pt;\">Bisoprolol</span></p>"
        },
        {
          "id": 43,
          "text": "<p><span style=\"font-size:12.0pt;\">Metoprolol</span></p>"
        },
        {
          "id": 44,
          "text": "<p><span style=\"font-size:12.0pt;\">Timolol</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 55-year-old man comes to the physician because of episodic retrosternal chest pain and shortness of breath for the past 6 months. His symptoms occur when he takes long walks or climbs stairs but resolve promptly with rest. He has a history of COPD. Physical examination shows mild expiratory wheezing over both lungs. Additional treatment with a beta blocker is considered. Which of the following agents should be avoided in this patient?</span></p>",
      "unique_key": "Q237695",
      "question_audio": null,
      "question_video": null,
      "map_id": 237695,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1000005
      ],
      "solution": "<p>This patient presents with symptoms of chronic stable angina and a history of COPD. Treatment with nonselective beta blockers should be avoided.</p><p>Cardioselective blockers (e.g., atenolol, bisoprolol) primarily block &beta;1 receptors in the heart, causing decreased heart rate, cardiac contractility, cardiac workload, and AVN conduction. While Nonselective beta blockers (e.g., pindolol, propranolol) inhibit all &beta; receptors and may cause bronchoconstriction, peripheral vasoconstriction, and metabolic imbalances (e.g., hypoglycemia and hyperglycemia, hypertriglyceridemia) in addition to cardiac effects.</p><p>Option A, B &amp; C : Atenolol, Bisoprolol and Metoprolol are cardioselective blocker, they should be preferred in patient with COPD, Diabetes and PVD having indication to start beta blocker therapy.</p><br><img class=\"w-100\" style=\"height:auto;display:block;vertical-align: middle;border:0; \"src=\"https://d10ehao5y6v0v4.cloudfront.net/V2LBNEETPG/PreTestQuiz/Pharmacology25112024/5E.jpg\"><br><img class=\"w-100\" style=\"height:auto;display:block;vertical-align: middle;border:0; \"src=\"https://d10ehao5y6v0v4.cloudfront.net/V2LBNEETPG/PreTestQuiz/Pharmacology25112024/5E1.jpg\"><p><strong>Reference:</strong> Basic &amp; Clinical Pharmacology, Fourteenth Edition By Bertram G. Katzung, Pg no. 164.</p>",
      "correct_choice_id": 44,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6,
      "choices": [
        {
          "id": 51,
          "text": "<p><span style=\"font-size:12.0pt;\">Labetalol</span></p>"
        },
        {
          "id": 52,
          "text": "<p><span style=\"font-size:12.0pt;\">Hydralazine</span></p>"
        },
        {
          "id": 53,
          "text": "<p><span style=\"font-size:12.0pt;\">Fenoldopam</span></p>"
        },
        {
          "id": 54,
          "text": "<p><span style=\"font-size:12.0pt;\">Nicardipine</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 70-year-old man comes to the ED because of blurry vision and headaches for the past 2 days. His temperature is 99 F, pulse is 90/min, and blood pressure is 230/130 mm-Hg. Fundoscopy shown below. A medication is given immediately. Five minutes later, his pulse is 75/min and blood pressure is 190/100 mm Hg. Which of the following drugs was most likely administered?<br><img class=\"w-100\" style=\"height:auto;display:block;vertical-align: middle;border:0; \"src=\"https://d10ehao5y6v0v4.cloudfront.net/V2LBNEETPG/PreTestQuiz/Pharmacology25112024/6Q.jpg\"></span></p>",
      "unique_key": "Q237696",
      "question_audio": null,
      "question_video": null,
      "map_id": 237696,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1000005
      ],
      "solution": "<p>This patient is experiencing a hypertensive emergency, which is characterised by an acute increase in blood pressure (&gt; 180/120 mm Hg) and signs of end-organ damage (e.g.,blurry vision, headaches, retinal flame hemorrhages, papilledema).</p><p>He was treated with a medication that decreases both the heart rate and systemic vascular resistance. Intravenous labetalol, a nonselective antagonist of beta receptors and alpha- 1 receptors, is used to treat severe gestational hypertension and hypertensive emergencies. Alpha-1 blockade causes peripheral vasodilation, which decreases blood pressure. Beta-1 receptor blockade decreases cardiac contractility and renin secretion, which further lowers blood pressure. In addition, the beta-1 blockade also decreases the heart rate by causing sinoatrial and AV node depression. Carvedilol and the nondihydropyridine calcium channel blocker diltiazem can cause a similar decrease in both blood pressure and heart rate.</p><p>Antihypertensives that only have a vasodilatory effect (e.g., hydralazine, nitroprusside, nicardipine, fenoldopam) cause an increase in heart rate (reflex tachycardia).</p><p>Option B: Intravenous hydralazine, which is a direct vasodilator that mainly affects peripheral arteries, can be used to treat hypertensive emergencies. However, the administration of hydralazine causes reflex tachycardia rather than the decrease in heart rate seen here. Fluid retention, angina, and drug-induced lupus can also occur as a result of hydralazine administration.</p><p>Option C: Fenoldopam is an intravenously administered D1-receptor agonist that is used to treat hypertensive emergencies. Fenoldopam causes the vasodilation of peripheral vessels and promotes natriuresis but its administration would result in reflex tachycardia rather than the decrease in heart rate seen here.</p><p>Option D: Intravenous nicardipine, a DHP-CCB, is used to treat hypertensive emergencies, primarily decrease the contractility of vascular smooth muscle cells and lower blood pressure by decreasing peripheral vascular resistance. However, the administration of DHP- CCBs causes reflex tachycardia rather than the decrease in heart rate seen here. DHP- CCBs can also cause peripheral edema and flushing. As a result of sinoatrial or AV node depression, a decrease in heart rate can occur following the administration of Non-DHP CCBs (e.g., verapamil, diltiazem).</p><p><strong>Reference:</strong> Basic &amp; Clinical Pharmacology, Fourteenth Edition By Bertram G. Katzung, Pg no. 166.</p>",
      "correct_choice_id": 51,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 7,
      "choices": [
        {
          "id": 61,
          "text": "<p><span style=\"font-size:12.0pt;\">Timolol</span></p>"
        },
        {
          "id": 62,
          "text": "<p><span style=\"font-size:12.0pt;\">Acetazolamide</span></p>"
        },
        {
          "id": 63,
          "text": "<p><span style=\"font-size:12.0pt;\">Apraclonidine</span></p>"
        },
        {
          "id": 64,
          "text": "<p><span style=\"font-size:12.0pt;\">Latanoprost</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 70-year-old man with chronic myopia comes to the ophthalmologist for regular check-up. Examination shows bilateral narrowing of peripheral visual fields, cupping of the optic discs, and elevated intraocular pressure. Gonioscopy shows no abnormalities. Which of the following first line of treatment for this patient ?</span></p>",
      "unique_key": "Q237697",
      "question_audio": null,
      "question_video": null,
      "map_id": 237697,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1000005
      ],
      "solution": "<p>The loss of peripheral vision, optic disc cupping, and elevated intraocular pressure in this patient with a normal gonioscopy are diagnostic of open-angle glaucoma.</p><p>Preferred first-line therapy are topical prostaglandin analogs like Latanoprost. Alternative options are Topical beta blockers alone and/or alpha-2 agonists OR Topical carbonic anhydrase inhibitors. For treatment of Refractory glaucoma, oral carbonic anhydrase inhibitors are used.</p><p><strong>Reference:</strong> Basic &amp; Clinical Pharmacology, Fourteenth Edition By Bertram G. Katzung, Pg no. 159.</p>",
      "correct_choice_id": 64,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 8,
      "choices": [
        {
          "id": 71,
          "text": "<p><span style=\"font-size:12.0pt;\">Verapamil</span></p>"
        },
        {
          "id": 72,
          "text": "<p><span style=\"font-size:12.0pt;\">Propranolol</span></p>"
        },
        {
          "id": 73,
          "text": "<p><span style=\"font-size:12.0pt;\">Flecainide</span></p>"
        },
        {
          "id": 74,
          "text": "<p><span style=\"font-size:12.0pt;\">Amiodarone</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 60-year-old man with COPD comes to the you with palpitations and dizziness since 1 week. Her pulse is 75/min and regular, BP is 3.110/80 mm-Hg. An ECG is shown. What is the first line therapy for her ?<br><img class=\"w-100\" style=\"height:auto;display:block;vertical-align: middle;border:0; \"src=\"https://d10ehao5y6v0v4.cloudfront.net/V2LBNEETPG/PreTestQuiz/Pharmacology25112024/8Q.jpg\"></span></p>",
      "unique_key": "Q237698",
      "question_audio": null,
      "question_video": null,
      "map_id": 237698,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1000005
      ],
      "solution": "<p>This patient's symptoms and ECG findings <strong>(narrow QRS complexes</strong>&nbsp;with an atrial rate of 240/min in a sawtooth pattern) are most consistent with <strong>atrial flutter</strong>. A mainstay of treatment of stable atrial flutter is to normalize the ventricular heart rate (rate control). However Consider rhythm control in the following patient groups:</p><ul><li>Failure of rate control strategy to control symptoms or achieve target heart rate (80bpm)</li><li>New-onset Atrial flutter</li><li>Acute illness that precipitated Atrial flutter</li><li>Other: tachycardia-induced cardiomyopathy, pregnancy, patient preference, younger patients</li></ul><p><strong>Drugs used for rate control include beta-blockers (e.g., esmolol, propranolol, metoprolol) and non-DHP CCBs (e.g., diltiazem, verapamil). Verapamil is commonly used as first-line therapy as rate control for atrial flutter particularly in patient with COPD, as beta blockers are to avoided in them. (Option B)</strong></p><br><img class=\"w-100\" style=\"height:auto;display:block;vertical-align: middle;border:0; \"src=\"https://d10ehao5y6v0v4.cloudfront.net/V2LBNEETPG/PreTestQuiz/Pharmacology25112024/8E.jpg\"><p>Option C : Flecainide, Selective use and state-dependent block of Na; slowed conduction velocity and pacemaker activity primarily used for Refractory ventricular arrhythmias. It can increased arrhythmias and CNS toxicity.</p><p>Option D : Amiodarone, strong K block produces marked prolongation of action potential and refractory period. Group 1 activity slows conduction velocity, group 2 and 4 activity confer additional anti-arrhythmic activity, used only for Refractory arrhythmias. Some of the side effects include thyroid abnormalities, deposits in skin and cornea, pulmonary fibrosis, optic neuritis, torsades (rare).</p><p><strong>Reference: </strong>Basic &amp; Clinical Pharmacology, Fourteenth Edition By Bertram G. Katzung Pg no. 245</p>",
      "correct_choice_id": 71,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 9,
      "choices": [
        {
          "id": 81,
          "text": "<p><span style=\"font-size:12.0pt;\">Hydrochlorothiazide</span></p>"
        },
        {
          "id": 82,
          "text": "<p><span style=\"font-size:12.0pt;\">Lithium</span></p>"
        },
        {
          "id": 83,
          "text": "<p><span style=\"font-size:12.0pt;\">TMP-SMX</span></p>"
        },
        {
          "id": 84,
          "text": "<p><span style=\"font-size:12.0pt;\">Metformin</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 45-year-old man is brought for a syncopal episode. He started on lisinopril for his HTN today. On arrival, he is fully oriented. His pulse is 100/min and blood pressure is 90/60 mm Hg. Concurrent treatment with which of the following agents most likely predisposed the patient to this episode?</span></p>",
      "unique_key": "Q237699",
      "question_audio": null,
      "question_video": null,
      "map_id": 237699,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1000005
      ],
      "solution": "<ul><li>The patient presents with a symptomatic hypotensive episode after initiating lisinopril (first- dose hypotension). ACE inhibitors work synergistically with other antihypertensive agents.</li><li>Here, Hydrochlorothiazide is a first-line agent for treating hypertension. Patients who are taking diuretics or are volume depleted are at higher risk for first-dose hypotension when additional antihypertensives such as ACE inhibitors are initiated, as in this patient.</li></ul><br><img class=\"w-100\" style=\"height:auto;display:block;vertical-align: middle;border:0; \"src=\"https://d10ehao5y6v0v4.cloudfront.net/V2LBNEETPG/PreTestQuiz/Pharmacology25112024/9E.jpg\"><br><p><strong>Reference : </strong>Basic &amp; Clinical Pharmacology, Fourteenth Edition By Bertram G. Katzung Pg no. 255, 256</p>",
      "correct_choice_id": 81,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 10,
      "choices": [
        {
          "id": 91,
          "text": "<p><span style=\"font-size:12.0pt;\">Metoclopramide</span></p>"
        },
        {
          "id": 92,
          "text": "<p><span style=\"font-size:12.0pt;\">Doxylamine</span></p>"
        },
        {
          "id": 93,
          "text": "<p><span style=\"font-size:12.0pt;\">Bismuth subsalicylate</span></p>"
        },
        {
          "id": 94,
          "text": "<p><span style=\"font-size:12.0pt;\">IV fluid</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 27-year-old woman G1P0, at 8 weeks' gestation comes for progressively worsening emesis, nausea, and a 2-kg weight loss over the past 2 weeks. The most recent bouts of vomiting occur around 3-4 times a day, She is currently taking ginger and vitamin B6 with limited relief. Her abdomen is soft and nontender. Urinalysis shows no abnormalities. Her hematocrit is 40%. In addition to oral fluid resuscitation, which of the following is the most appropriate next step in management?</span></p>",
      "unique_key": "Q237700",
      "question_audio": null,
      "question_video": null,
      "map_id": 237700,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1000005
      ],
      "solution": "<p>Given clinical scenario suggest morning sickness with no clinical signs of dehydration. If vitamin B6 (pyridoxine) alone does not improve nausea and vomiting of pregnancy, doxylamine should be administer</p><p>Bismuth subsalicylate is used to treat patients with nausea and emesis. However, this medication is contraindicated during pregnancy because it can cross the placenta and may adversely affect the fetus. Antacids, preferably containing aluminum or calcium, can be used as adjunctive therapy in pregnant women with acid reflux.</p><p>Dietary changes (e.g., cutting out spicy, high-fat, and/or acidic foods) and avoidance of triggers (e.g., poorly ventilated rooms, loud noises, strong and/or unpleasant odors) may also improve nausea. If treatment with pyridoxine and doxylamine is unsuccessful, antiemetics such as metaclopromide (A), diphenhydramine, or promethazine can be administered.</p><p>(D) In patients with severe dehydration and metabolic alkalosis (due to frequent vomiting), IV rehydration with electrolyte supplementation should be initiated. Chlorpromazine and methylprednisolone should be used with caution and only in patients who have not responded to other treatments.</p><p><strong>Reference: </strong>Basic &amp; Clinical Pharmacology, Fourteenth Edition By Bertram G. Katzung Pg no. 283</p>",
      "correct_choice_id": 92,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11,
      "choices": [
        {
          "id": 101,
          "text": "<p><span style=\"font-size:12.0pt;\">Calcium with vitamin D</span></p>"
        },
        {
          "id": 102,
          "text": "<p><span style=\"font-size:12.0pt;\">Omeprazole</span></p>"
        },
        {
          "id": 103,
          "text": "<p><span style=\"font-size:12.0pt;\">Pyridoxine</span></p>"
        },
        {
          "id": 104,
          "text": "<p><span style=\"font-size:12.0pt;\">Folic acid</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 42-year-old woman presents with abdominal pain with nausea and vomiting. Current medications include prednisone and naproxen. Examination shows a rigid abdomen with rebound tenderness; bowel sounds are hypoactive. Laboratory studies show a leukocyte count of 13,300/mm3 and an erythrocyte sedimentation rate of 70 mm/h. An x-ray of the chest is shown. Treatment with which of the following could have prevented this complication ?<br><img class=\"w-100\" style=\"height:auto;display:block;vertical-align: middle;border:0; \"src=\"https://d10ehao5y6v0v4.cloudfront.net/V2LBNEETPG/PreTestQuiz/Pharmacology25112024/11Q.jpg\"></span></p>",
      "unique_key": "Q237701",
      "question_audio": null,
      "question_video": null,
      "map_id": 237701,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1000005
      ],
      "solution": "<p>Patient with given CXR suggesting air under diaphragm- peptic perforation leading to chemical peritonitis. Clinical signs like rigid abdomen with rebound tenderness adding to the diagnosis. Patient is on prednisone and naproxen both of are risk factor for perforation. (Chronic NSAID use associated with a fourfold risk of developing PUD and Increases the risk for complications of PUD like perforation)</p><p>Initial Treatment includes NPO, volume resuscitation and supportive care till the surgical management with laparotomy is done.</p><ul><li>Prophylactic agents</li><ul><li>PPIs (preferred for patients with moderate-to-high risk factors): e.g., pantoprazole</li><li>H2 receptor blockers (may be used as an alternative): e.g., famotidine</li></ul><li>Duration: Continue prophylaxis for as long as significant risk factors are present or until critical illness resolves.</li></ul><br><img class=\"w-100\" style=\"height:auto;display:block;vertical-align: middle;border:0; \"src=\"https://d10ehao5y6v0v4.cloudfront.net/V2LBNEETPG/PreTestQuiz/Pharmacology25112024/11E.jpg\"><br><p><strong>Reference:</strong> Basic &amp; Clinical Pharmacology, Fourteenth Edition By Bertram G. Katzung Pg no. 641</p>",
      "correct_choice_id": 102,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 12,
      "choices": [
        {
          "id": 111,
          "text": "<p><span style=\"font-size:12.0pt;\">Indomethacin</span></p>"
        },
        {
          "id": 112,
          "text": "<p><span style=\"font-size:12.0pt;\">Aspirin</span></p>"
        },
        {
          "id": 113,
          "text": "<p><span style=\"font-size:12.0pt;\">Probenecid</span></p>"
        },
        {
          "id": 114,
          "text": "<p><span style=\"font-size:12.0pt;\">Allopurinol</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 32-year-old woman presents with a 1-day history of severe pain and swelling of her left great toe. She has had similar episodes sporadically over the past 1 years. Examination shows erythema, warmth, and tenderness of the left first metatarsophalangeal joint. The most appropriate next step in treatment is ?</span></p>",
      "unique_key": "Q237702",
      "question_audio": null,
      "question_video": null,
      "map_id": 237702,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1000005
      ],
      "solution": "<p>Patient with Arthritis of the metatarsophalangeal joint suggestive for acute gout. NSAIDs, such as indomethacin or ibuprofen, which reversibly inhibit prostaglandin synthesis by inhibiting both COX-1 and COX-2, are the first line in the management of an acute gout flare.</p><p>Other drugs that can be used in a severe flare of gout include glucocorticoids and colchicine.</p><p>B: Aspirin, an NSAID that irreversibly inhibits cyclooxygenase (COX), is avoided in gout as it inhibits uric acid secretion at low doses (1&ndash;2 g/day).</p><p>C: Uricosuric drugs like probenecid reduce serum urate by increasing renal elimination of uric acid. They are indicated in the management of chronic hyperuricemia and are not useful in the setting of an acute gout flare.</p><p>D: Xanthine oxidase inhibitors (e.g., allopurinol, febuxostat) can be used to prevent flares of gout but should not be used within the first 2 weeks of an acute flare because they can worsen the acute gout attack.</p><p><strong>Reference:</strong> Basic &amp; Clinical Pharmacology, Fourteenth Edition By Bertram G. Katzung Pg no. 335</p>",
      "correct_choice_id": 111,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 13,
      "choices": [
        {
          "id": 121,
          "text": "<p><span style=\"font-size:12.0pt;\">2,3</span></p>"
        },
        {
          "id": 122,
          "text": "<p><span style=\"font-size:12.0pt;\">1,3</span></p>"
        },
        {
          "id": 123,
          "text": "<p><span style=\"font-size:12.0pt;\">1,4</span></p>"
        },
        {
          "id": 124,
          "text": "<p><span style=\"font-size:12.0pt;\">2,4</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following statements are FALSE?<br>1. Zileuton is LTD4 receptor antagonist.<br>2. Zileuton is 5-lipoxygenase inhibitor.<br>3. Monteleukast is LTD4 receptor antagonist.<br>4. Monteleukast is 5-lipoxygenase inhibitor.</span></p>",
      "unique_key": "Q237703",
      "question_audio": null,
      "question_video": null,
      "map_id": 237703,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1000005
      ],
      "solution": "<ul><li>Two approaches to interrupting the leukotriene pathway have been pursued: inhibition of 5-lipoxygenase, thereby preventing leukotriene synthesis; and inhibition of the binding of LTD 4 to its receptor on target tissues, thereby preventing its action.</li><li>Efficacy in blocking airway responses to exercise and to antigen challenge has been shown for drugs in both categories: <strong>zileuton, </strong>a 5-lipoxygenase inhibitor, and <strong>zafirlukast </strong>and <strong>montelukast, </strong>LTD 4 &ndash;receptor antagonists.</li><li>All have been shown to improve asthma control and to reduce the frequency of asthma exacerbations in outpatient clinical trials.</li><li>Their effects on symptoms, airway calibre, bronchial reactivity, and airway inflammation are less marked than the effects of inhaled corticosteroids, but they are more nearly equal in reducing the frequency of exacerbations.</li><li>Their principal advantage is that they are taken orally; some patients-especially children-comply poorly with inhaled therapies. Montelukast is approved for children as young as 6 years of age.</li></ul><p><strong>Reference:</strong> LANG' Basic &amp; clinical pharmacology by Bertram G. Katzung, Susen B. Masters and Anthony J. Trevor 12<sup>th</sup> edition. Chapter 20- Drugs used in asthma by Dr. Homer A. Boushy, MD. Page no. 349</p>",
      "correct_choice_id": 123,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 14,
      "choices": [
        {
          "id": 131,
          "text": "<p><span style=\"font-size:12.0pt;\">Lorazepam</span></p>"
        },
        {
          "id": 132,
          "text": "<p><span style=\"font-size:12.0pt;\">Diazepam</span></p>"
        },
        {
          "id": 133,
          "text": "<p><span style=\"font-size:12.0pt;\">Clonazepam</span></p>"
        },
        {
          "id": 134,
          "text": "<p><span style=\"font-size:12.0pt;\">Alprazolam</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 42 year old chronic alcoholic presents to the emergency department with altered sensorium and seizures. He has not consumed alcohol for the last two days. On investigations, his serum ALT is 150, AST is 180 and GGT is 563 units per litre. Best drug for first line management of this patient is?</span></p>",
      "unique_key": "Q237704",
      "question_audio": null,
      "question_video": null,
      "map_id": 237704,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1000005
      ],
      "solution": "<p><strong>Lorazepam</strong></p><p>Has slow oral absorption. Being less lipid-soluble than diazepam, its rate of entry in the brain is slower. The plasma t&frac12; is shorter (10-20 hours); no active metabolite is produced, since it is directly conjugated with glucuronic acid, and is suitable for older patients.</p><p>However, it is quite sedative and capable of producing marked amnesia when injected i.v. Injection site complications are minor. Therefore, it is the only BZD recommended for i.m. use. Lorazepam has been preferred for short lasting anxiety states, panic, OCD and tension syndromes, as well as for psychosomatic diseases and for i.v. use in status epilepticus.</p><p><strong>Reference:</strong> Kdt 8<sup>th</sup>/e p494</p>",
      "correct_choice_id": 131,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 15,
      "choices": [
        {
          "id": 141,
          "text": "<p><span style=\"font-size:12.0pt;\">Docosanol</span></p>"
        },
        {
          "id": 142,
          "text": "<p><span style=\"font-size:12.0pt;\">Foscarnet</span></p>"
        },
        {
          "id": 143,
          "text": "<p><span style=\"font-size:12.0pt;\">Penciclovir</span></p>"
        },
        {
          "id": 144,
          "text": "<p><span style=\"font-size:12.0pt;\">Trifluridine</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 50 years old patient brought to emergency in unconscious. Relatives give history of high grade fever since 3-4 days which was unattended. His pulse rate is 66 bpm, BP is 130/86 mm Hg, Temperature is 102.3&deg; F, SpO2 is 98 % on air. CSF sample was collected and culture examination was done. CSF culture was positive for HSV-1. So, he was diagnosed as herpetic encephalitis and intravenous acyclovir was started. Patient was rapidly recovering from symptoms. On 10th day of the treatment he complained of fever with chills. So, second CSF sample was collected for drug sensitivity examination. In this report, Resistance was formed against acyclovir. Which drug can be given by intravenous route in acyclovir resistant HSV infection?</span></p>",
      "unique_key": "Q237705",
      "question_audio": null,
      "question_video": null,
      "map_id": 237705,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1000005
      ],
      "solution": "<img class=\"w-100\" style=\"height:auto;display:block;vertical-align: middle;border:0; \"src=\"https://d10ehao5y6v0v4.cloudfront.net/V2LBNEETPG/PreTestQuiz/Pharmacology25112024/15E.jpg\"><br><p><strong>Reference :</strong> LANG' Basic &amp; clinical pharmacology by Bertram G. Katzung, Susen B. Masters and Anthony J. Trevor 12<sup>th</sup> edition. Chapter 49- Antiviral Agents by Dr. Sharon Safrin,MD. Page no. 865</p>",
      "correct_choice_id": 142,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 16,
      "choices": [
        {
          "id": 151,
          "text": "<p><span style=\"font-size:12.0pt;\">Anastrozole</span></p>"
        },
        {
          "id": 152,
          "text": "<p><span style=\"font-size:12.0pt;\">Bleomycin</span></p>"
        },
        {
          "id": 153,
          "text": "<p><span style=\"font-size:12.0pt;\">Carmustine</span></p>"
        },
        {
          "id": 154,
          "text": "<p><span style=\"font-size:12.0pt;\">Imatinib</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 56-year-old presents with fluid retention and edema. With which of the following drugs is this patient most likely being treated?</span></p>",
      "unique_key": "Q237706",
      "question_audio": null,
      "question_video": null,
      "map_id": 237706,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1000005
      ],
      "solution": "<ul><li>Imatinib is a protein-tyrosine kinase inhibitor that inhibits the bcl-abr tyrosine kinase, which is the constitutive abnormal tyrosine kinase produced by the Philadelphia chromosome in patients with CML. <strong>Imatinib is associated with the development of fluid retention, including pleural effusion, ascites, pulmonary edema, and rapid weight gain.</strong></li><li>Anastrozole is an aromatase inhibitor used to treat breast cancer. It is associated with hot flashes, thromboembolism, osteoporosis, and bone fractures.</li><li>Bleomycin is an intercalating agent that complexes iron-forming reactive oxygen species and induces DNA strand breaks. It is used to treat squamous cell carcinoma, both Hodgkin and non-Hodgkin lymphoma as well as testicular carcinoma. This agent is commonly associated with the development of pulmonary fibrosis.</li></ul><p><strong>Reference:</strong> Basic &amp; clinical Pharmacology by Bertram G. Katzung, 15<sup>th</sup> Edition, pg no. 1003</p>",
      "correct_choice_id": 154,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 17,
      "choices": [
        {
          "id": 161,
          "text": "<p><span style=\"font-size:12.0pt;\">Corneal deposits</span></p>"
        },
        {
          "id": 162,
          "text": "<p><span style=\"font-size:12.0pt;\">Hypotension</span></p>"
        },
        {
          "id": 163,
          "text": "<p><span style=\"font-size:12.0pt;\">Nephrotoxicity</span></p>"
        },
        {
          "id": 164,
          "text": "<p><span style=\"font-size:12.0pt;\">Seizures</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 58-year-old woman with a history of severe recalcitrant plaque psoriasis comes to the physician because of a recurrence of erythematous plaques despite current treatment measures.Treatment is begun with a calcineurin inhibitor that binds cyclophilin and blocks T cell activation by preventing IL-2 transcription. This patient is at greatest risk of experiencing which of the followingadverse effects as a result of this drug?</span></p>",
      "unique_key": "Q237707",
      "question_audio": null,
      "question_video": null,
      "map_id": 237707,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1000005
      ],
      "solution": "<ul><li>Cyclosporine is a calcineurin inhibitor that induces immunosuppression by binding cyclophilin and inhibiting interleukin (IL)-1 and IL-2 receptor production and inhibits macrophage/T-cell interaction and T-cell responsiveness through the regulation of gene transcription. Cyclosporine is used in the treatment of transplant rejection prophylaxis, severe psoriasis, and rheumatoid arthritis</li><li>Nephrotoxicity, characterized by an elevated BUN (&gt;35-45 mq/dL) and creatinine (&gt;2.0-2.5 mg/dL), is the most common adverse effect of systemic cyclosporine therapy and has been documented in all types of patients who are receiving cyclosporine. Factors that increase the risk of nephrotoxicity with cyclosporine include age older than 50 years, concomitant nephrotoxic medications, and the period 6 to 8 weeks posttransplant (if used in transplant rejection prophylaxis).</li><li>Cyclosporine-induced nephrotoxicity is most likely due to intense renal vasoconstriction, which leads to increases in serum creatinine, arterial blood pressure, and serum potassium. Cyclosporin causes nephrotoxicity, severe hypertension, gingival hyperplasia, hyperlipidemia, and hyperglycemia.</li><li>Corneal deposits are not a side effect of cyclosporine; however, it is commonly seen with hydroxychloroquine usage.</li><li>Hydroxychloroquine is used to treat malaria, SLE, and rheumatoid arthritis. It is contraindicated for use in psoriasis because it causes psoriasis exacerbation.</li><li>Although seizures can occur in patients who are taking cyclosporine, most patients who have seizures experience a single seizure with no recurrence after dose reduction. Multiple factors (e.g., hypertension, high-dose methylprednisolone, hypocholesterolemia, nephrotoxicity, and associated high serum cyclosporine levels) seem to be related to the neurologic manifestations of cyclosporine toxicity.</li></ul><p><strong>Reference:</strong> Basic &amp; Clinical Pharmacology, Fourteenth Edition by Bertram G. Katzung Pg no. 991-993</p>",
      "correct_choice_id": 163,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 18,
      "choices": [
        {
          "id": 171,
          "text": "<p><span style=\"font-size:12.0pt;\">Abatacept</span></p>"
        },
        {
          "id": 172,
          "text": "<p><span style=\"font-size:12.0pt;\">Azathioprine</span></p>"
        },
        {
          "id": 173,
          "text": "<p><span style=\"font-size:12.0pt;\">Cyclosporine</span></p>"
        },
        {
          "id": 174,
          "text": "<p><span style=\"font-size:12.0pt;\">Seizures</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 40-year-old woman with renal allograft is currently taking an immunosuppressive drug. Laboratory examination shows a uric acid level of 10.5 mg/dL. Treatment with allopurinol is begun, necessitating a reduction in the dose of the immunosuppressive drug. Which of the following immunosuppressive drugs is this patient most likely taking?</span></p>",
      "unique_key": "Q237708",
      "question_audio": null,
      "question_video": null,
      "map_id": 237708,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1000005
      ],
      "solution": "<ul><li><strong>In this question, you must identify the immunosuppressive drug that interacts with allopurinol, subsequently requiring a dose reduction of the immunosuppressant agent. </strong></li><li><strong>Azathioprine is an immunosuppressant that ultimately inhibits T-lymphocyte proliferation. This agent is converted to 6-mercaptopurine, which inhibits DNA purine synthesis and subsequent T-cell proliferation. </strong></li><li><strong>Xanthine oxidase is instrumental in the metabolism of azathioprine metabolites, and coadministration with allopurinol (an inhibitor of xanthine oxidase) can result in azathioprine toxicity. Because azathioprine interacts with allopurinol in the question stem, azathioprine is the correct</strong>.</li></ul><p><strong>Reference:</strong> Basic &amp; Clinical Pharmacology, Fourteenth Edition By Bertram G. KatzungPg no. 1004-1005</p>",
      "correct_choice_id": 172,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 19,
      "choices": [
        {
          "id": 181,
          "text": "<p><span style=\"font-size:12.0pt;\">Juvenile myoclonic epilepsy</span></p>"
        },
        {
          "id": 182,
          "text": "<p><span style=\"font-size:12.0pt;\">Infantile spasms</span></p>"
        },
        {
          "id": 183,
          "text": "<p><span style=\"font-size:12.0pt;\">Dravet syndrome</span></p>"
        },
        {
          "id": 184,
          "text": "<p><span style=\"font-size:12.0pt;\">Lennox Gastaut syndrome</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">ACTH is the treatment of choice for which of the following syndrome?</span></p>",
      "unique_key": "Q237709",
      "question_audio": null,
      "question_video": null,
      "map_id": 237709,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1000005
      ],
      "solution": "<p><strong>Infantile spasms (hypsarrhythmia)</strong></p><p>Therapy of this condition is unsatisfactory, antiepileptic drugs are generally useless.</p><p>Corticosteroids(ACTH) afford symptomatic relief but cannot be used for long-term due to adverse effects. Clonazepam, valproate and vigabatrin may afford some relief.</p><p>Drug of choice for infantile spasms is ACTH whereas infantile spasms associated with tuberous sclerosis are treated with vigabatrin.</p><p><strong>Reference:</strong> Kdt 8<sup>th</sup>/e p450, Katzung 11/e p418</p>",
      "correct_choice_id": 182,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 20,
      "choices": [
        {
          "id": 191,
          "text": "<p><span style=\"font-size:12.0pt;\">Cefixime</span></p>"
        },
        {
          "id": 192,
          "text": "<p><span style=\"font-size:12.0pt;\">Cefoperazone</span></p>"
        },
        {
          "id": 193,
          "text": "<p><span style=\"font-size:12.0pt;\">Ceftobiprole</span></p>"
        },
        {
          "id": 194,
          "text": "<p><span style=\"font-size:12.0pt;\">Ceftazidime</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A patient on warfarin therapy for chronic atrial fibrillation. He was prescribed cephalosporin following a lower respiratory tract infection. He then presents with hemarthrosis. Which of the following cephalosporin is likely to have caused this?</span></p>",
      "unique_key": "Q237710",
      "question_audio": null,
      "question_video": null,
      "map_id": 237710,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1000005
      ],
      "solution": "<p><strong>Drugs Enhancing anticoagulant action of warfarin</strong></p><ol><li>Broad-spectrum antibiotics: inhibit gut flora and reduce vit K production.</li><li>Some cephalosporins (ceftriaxone, cefoperazone) cause hypoprothrombinemia by the same mechanism as warfarin-produce additive action.</li><li>Aspirin: inhibits platelet aggregation and causes g.i. bleeding-this may be hazardous in anticoagulated patients.</li><li>Long acting sulfonamides, indomethacin, phenytoin and probenecid: displace warfarin from plasma protein binding.</li><li>Chloramphenicol, erythromycin, celecoxib, cimetidine, allopurinol, amiodarone and metronidazole: inhibit warfarin metabolism.</li><li>Tolbutamide and phenytoin: inhibit warfarin metabolism and <em>vice versa</em>.</li><li>Liquid paraffin (habitual use): reduces vit K absorption.</li></ol><p><strong>Reference:</strong> Kdt 8<sup>th</sup>/e p670</p>",
      "correct_choice_id": 192,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 21,
      "choices": [
        {
          "id": 201,
          "text": "<p><span style=\"font-size:12.0pt;\">Sitagliptin</span></p>"
        },
        {
          "id": 202,
          "text": "<p><span style=\"font-size:12.0pt;\">Vildagliptin</span></p>"
        },
        {
          "id": 203,
          "text": "<p><span style=\"font-size:12.0pt;\">Linagliptin</span></p>"
        },
        {
          "id": 204,
          "text": "<p><span style=\"font-size:12.0pt;\">Saxagliptin</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 70 year old patient has diabetes mellitus and hypertension. He presents with a late stage chronic kidney. Which of the following anti-diabetic drugs require least dose modification in renal disease?</span></p>",
      "unique_key": "Q237711",
      "question_audio": null,
      "question_video": null,
      "map_id": 237711,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1000005
      ],
      "solution": "<p><strong>DPP-4 Inhibitors:</strong></p><p><strong>Sitagliptin, vildagliptin, saxagliptin, alogliptin and linagliptin </strong>prolong the action of endogenous GLP-1 by inhibiting its metabolism through DPP-4:</p><ul><li>Unlike incretin-mimetic drugs, these do not cause nausea or weight loss.</li><li><strong>Most common </strong>adverse effect of DPP-4 inhibitors is <strong>nasopharyngitis </strong>and upper respiratory tract infections. These drugs are also associated with <strong>acute pancreatitis</strong>.</li><ul><li>DPP-4 inhibitors are <strong>effective orally</strong>.</li><li>These drugs require dose adjustment in renal failure except</li></ul></ul><p><strong>linagliptin.</strong></p><ul><li>Vildagliptin can cause hepatitis and requires dose adjustment in both renal as well as hepatic disease.</li><li>Linagliptin and saxagliptin increase the risk of heart failure.</li></ul><p><strong>Reference</strong>: Goodman &amp; Gilman 13<sup>th</sup>/e p879</p>",
      "correct_choice_id": 203,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 22,
      "choices": [
        {
          "id": 211,
          "text": "<p><span style=\"font-size:12.0pt;\">Lispro</span></p>"
        },
        {
          "id": 212,
          "text": "<p><span style=\"font-size:12.0pt;\">Aspart</span></p>"
        },
        {
          "id": 213,
          "text": "<p><span style=\"font-size:12.0pt;\">Glargine</span></p>"
        },
        {
          "id": 214,
          "text": "<p><span style=\"font-size:12.0pt;\">Glulisine</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following is not a short or rapid-acting insulin?</span></p>",
      "unique_key": "Q237712",
      "question_audio": null,
      "question_video": null,
      "map_id": 237712,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1000005
      ],
      "solution": "<ul><li><strong>Glargine</strong> is a <strong>long-acting insulin</strong>, designed to provide a <strong>steady basal insulin level</strong> over a period of time (typically 24 hours), making it unsuitable for rapid glucose control.</li><li><strong>Lispro, Aspart, and Glulisine</strong> are <strong>rapid-acting insulins</strong> that act within <strong>15-20 minutes</strong> and are typically used <strong>before meals (prandial insulin)</strong> to manage postprandial glucose spikes.</li></ul><ul><li><strong>Rapid-acting insulins</strong>:</li><ul><li><strong>Lispro</strong>, <strong>Aspart, Glulisine</strong></li><li>Onset: <strong>15-20 mins</strong>, used as <strong>prandial insulin</strong>.</li></ul><li><strong>Short-acting insulin</strong>:</li><ul><li><strong>Regular insulin</strong> (can be used in emergencies like <strong>DKA</strong>).</li></ul><li><strong>Long-acting insulin</strong>:</li><ul><li><strong>Glargine, Detemir, Degludec</strong> (used for maintaining <strong>basal insulin levels</strong>).</li></ul></ul><p><strong>Reference</strong>: Essentials of Medical Pharmacology, KD Tripathi, 8th Edition, Page 285-286.</p>",
      "correct_choice_id": 213,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 23,
      "choices": [
        {
          "id": 221,
          "text": "<p><span style=\"font-size:12.0pt;\">Anastrozole</span></p>"
        },
        {
          "id": 222,
          "text": "<p><span style=\"font-size:12.0pt;\">Alendronate</span></p>"
        },
        {
          "id": 223,
          "text": "<p><span style=\"font-size:12.0pt;\">Raloxifene</span></p>"
        },
        {
          "id": 224,
          "text": "<p><span style=\"font-size:12.0pt;\">Testosterone</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 65-year-old woman was admitted to the hospital due to severe thoracic pain after a fall. She has a history of mastectomy for breast cancer 10 years ago. An x-ray showed a fracture of three ribs and advanced osteoporosis. Therapy was initiated with a drug that could increase bone mass index and reduce the risk of breast cancer reactivation. Which of the following drugs was most likely administered?</span></p>",
      "unique_key": "Q237713",
      "question_audio": null,
      "question_video": null,
      "map_id": 237713,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1000005
      ],
      "solution": "<p><strong>Raloxifene</strong> is a <strong>selective estrogen receptor modulator (SERM)</strong>. It has an <strong>agonistic effect on bones</strong>, helping to increase bone mass by reducing bone resorption, making it beneficial for treating <strong>postmenopausal osteoporosis</strong>. At the same time, it acts as an <strong>antagonist on breast tissue</strong>, reducing the risk of <strong>breast cancer reactivation</strong>, which makes it particularly suitable for women with both osteoporosis and a history of breast cancer.</p><ul><li><strong>Raloxifene</strong> is used in the <strong>prevention and treatment of osteoporosis</strong> in postmenopausal women.</li><li>It also has a role in <strong>reducing the risk of breast cancer</strong>, especially in women with risk factors.</li><li>While it is less effective at increasing bone mass compared to <strong>bisphosphonates</strong>, its additional benefit of reducing breast cancer risk makes it a key option in certain cases.</li></ul><ul><li><strong>A. Anastrozole</strong>: Reduces breast cancer risk but further decreases estrogen levels, <strong>worsening bone mass</strong>.</li><li><strong>B. Alendronate</strong>: Increases bone mass but does not reduce breast cancer risk; used primarily for osteoporosis management.</li><li><strong>D. Testosterone</strong>: Not used for postmenopausal osteoporosis; typically used in androgen deficiency.</li></ul><p><strong>Reference: </strong>KD Tripathi Essential of Pharmacology, 8th Edition, Page No. 338-339</p>",
      "correct_choice_id": 223,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 24,
      "choices": [
        {
          "id": 231,
          "text": "<p><span style=\"font-size:12.0pt;\">Gossypol</span></p>"
        },
        {
          "id": 232,
          "text": "<p><span style=\"font-size:12.0pt;\">Mifepristone</span></p>"
        },
        {
          "id": 233,
          "text": "<p><span style=\"font-size:12.0pt;\">Atosiban</span></p>"
        },
        {
          "id": 234,
          "text": "<p><span style=\"font-size:12.0pt;\">Clomiphene</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">An obstetrician wants to perform a Medical Termination of Pregnancy (MTP) for a patient with an unwanted pregnancy and plans to use an anti-progesterone. Which of the following is an anti-progesterone?</span></p>",
      "unique_key": "Q237714",
      "question_audio": null,
      "question_video": null,
      "map_id": 237714,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1000005
      ],
      "solution": "<p><strong>Mifepristone</strong> is an <strong>anti-progesterone</strong> medication used in medical termination of pregnancy (MTP). It works by blocking the effects of progesterone, which is necessary for maintaining pregnancy.</p><ul><li><strong>Mifepristone</strong> has multiple uses including:</li><ul><li><strong>Termination of pregnancy</strong>: Induces abortion by blocking progesterone.</li><li><strong>Cervical ripening</strong>: Prepares the cervix for labor.</li><li><strong>Postcoital contraception</strong>: Emergency contraceptive.</li><li><strong>Cushing's syndrome</strong>: Acts as a glucocorticoid antagonist.</li><li><strong>Endometriosis</strong> and <strong>Uterine fibroids</strong>: Used in managing these conditions.</li><li><strong>Progesterone receptor positive breast cancers</strong> and <strong>Meningioma</strong>: Provides adjunctive treatment.</li></ul></ul><ul><li><strong>A. Gossypol</strong>: A nonsteroidal compound derived from cottonseed used as a male contraceptive by reducing sperm motility.</li><li><strong>C. Atosiban</strong>: An oxytocin antagonist used to suppress premature uterine contractions, not for abortion.</li><li><strong>D. Clomiphene</strong>: An anti-estrogen used to treat infertility by inducing ovulation.</li></ul><p><strong>References:</strong></p><ul><li>Goodman &amp; Gilman's The Pharmacological Basis of Therapeutics, 13th Edition, Pages 811-813, 815-816</li><li>Essentials of Medical Pharmacology by KD Tripathi, 8th Edition, Pages 353, 359</li></ul>",
      "correct_choice_id": 232,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 25,
      "choices": [
        {
          "id": 241,
          "text": "<p><span style=\"font-size:12.0pt;\">Metronidazole</span></p>"
        },
        {
          "id": 242,
          "text": "<p><span style=\"font-size:12.0pt;\">Fluconazole</span></p>"
        },
        {
          "id": 243,
          "text": "<p><span style=\"font-size:12.0pt;\">Mebendazole</span></p>"
        },
        {
          "id": 244,
          "text": "<p><span style=\"font-size:12.0pt;\">Iodoquinol</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Maya, a 45-year-old woman, presented with bloody stools, diarrhea, and abdominal cramps. She was diagnosed with amoebiasis and treated accordingly. Two weeks later, during a follow-up visit, a white cheesy patch on her tongue that could be cleaned by scraping was noted. Which of the following drugs is most likely responsible for this adverse event?</span></p>",
      "unique_key": "Q237715",
      "question_audio": null,
      "question_video": null,
      "map_id": 237715,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1000005
      ],
      "solution": "<p>The white cheesy patch on the tongue, which can be cleaned by scraping, indicates <strong>oral candidiasis. Metronidazole</strong>, used to treat amoebiasis, can disrupt the normal oral and gastrointestinal flora, leading to opportunistic infections like candidiasis.</p><ul><li><strong>Metronidazole</strong> is a first-line treatment for amoebiasis and can disrupt normal flora, increasing the risk of infections such as candidiasis.</li><li><strong>Oral candidiasis</strong> is a common adverse effect associated with antibiotics or drugs that disturb normal flora balance.</li></ul><ul><li><strong>B. Fluconazole</strong>: An antifungal medication used to treat candidiasis, not to cause it.</li><li><strong>C. Mebendazole</strong>: An antihelminthic used for treating worm infections; it does not cause candidiasis.</li><li><strong>D. Iodoquinol</strong>: Used for treating luminal amoebiasis; it does not typically cause candidiasis.</li></ul><p><strong>References:</strong></p><ul><li>Katzung, Basic &amp; Clinical Pharmacology, 14th Edition, Page 929</li></ul>",
      "correct_choice_id": 241,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    }
  ]
}